Randomised clinical trial: a comparative study of 10-day sequential therapy with 7-day standard triple therapy for Helicobacter pylori infection in naïve patients (Q57225807)

From Wikidata

Jump to navigation Jump to search

scientific article published on 08 November 2011

Language	Label	Description	Also known as
English	Randomised clinical trial: a comparative study of 10-day sequential therapy with 7-day standard triple therapy for Helicobacter pylori infection in naïve patients	scientific article published on 08 November 2011

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22066530%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Randomised clinical trial: a comparative study of 10-day sequential therapy with 7-day standard triple therapy for Helicobacter pylori infection in naïve patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22066530%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

0 references

Helicobacter pylori

1 reference

based on heuristic

inferred from title

Helicobacter pylori infectious disease

1 reference

based on heuristic

inferred from title

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22066530%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

author name string

H G Park

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22066530%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

M K Jung

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22066530%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

J T Jung

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22066530%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

J G Kwon

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22066530%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

E Y Kim

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22066530%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

H E Seo

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22066530%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

J H Lee

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22066530%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

C H Yang

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22066530%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

E S Kim

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22066530%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

K B Cho

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22066530%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

K S Park

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22066530%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

S H Lee

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22066530%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

K O Kim

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22066530%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

language of work or name

0 references

publication date

8 November 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22066530%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Alimentary Pharmacology & Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22066530%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

35

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22066530%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22066530%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

56-65

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22066530%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Helicobacter pyloriInfection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04902.X

21 January 2018

Second Asia-Pacific Consensus Guidelines for Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04902.X

21 January 2018

"Cervia II Working Group Report 2006": guidelines on diagnosis and treatment of Helicobacter pylori infection in Italy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04902.X

21 January 2018

American College of Gastroenterology guideline on the management of Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04902.X

21 January 2018

Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04902.X

21 January 2018

A meta-analysis of short versus long therapy with a proton pump inhibitor, clarithromycin and either metronidazole or amoxycillin for treating Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04902.X

21 January 2018

Comparison of 7-day and 14-day proton pump inhibitor-containing triple therapy for Helicobacter pylori eradication: neither treatment duration provides acceptable eradication rate in Korea

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04902.X

21 January 2018

Meta-analysis: sequential therapy appears superior to standard therapy for Helicobacter pylori infection in patients naive to treatment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04902.X

21 January 2018

Efficacy of moxifloxacin-based triple therapy as second-line treatment for Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04902.X

21 January 2018

Ten-day sequential treatment for Helicobacter pylori eradication in clinical practice.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04902.X

21 January 2018

Sequential therapy vs. standard triple therapies for Helicobacter pylori infection: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04902.X

21 January 2018

Diagnosis and treatment guidelines for Helicobacter pylori infection in Korea

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04902.X

21 January 2018

Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04902.X

21 January 2018

Predictors of failure of Helicobacter pylori eradication with the standard 'Maastricht triple therapy'.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04902.X

21 January 2018

Sequential Therapy versus Standard Triple-Drug Therapy for Helicobacter pylori Eradication

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04902.X

21 January 2018

Ten and eight-day sequential therapy in comparison to standard triple therapy for eradicating Helicobacter pylori infection: a randomized controlled study on efficacy and tolerability

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04902.X

21 January 2018

Eradication of Helicobacter pylori with triple therapy: an epidemiologic analysis of trends in Turkey over 10 years

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04902.X

21 January 2018

Seven-day therapy for Helicobacter pylori in the United States

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04902.X

21 January 2018

H pylori antibiotic resistance: prevalence, importance, and advances in testing

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04902.X

21 January 2018

A systematic review of Helicobacter pylori eradication therapy--the impact of antimicrobial resistance on eradication rates

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04902.X

21 January 2018

Distribution of antibiotic MICs for Helicobacter pylori strains over a 16-year period in patients from Seoul, South Korea

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04902.X

21 January 2018

Changing pattern of antimicrobial resistance of Helicobacter pylori in Korean patients with peptic ulcer diseases

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04902.X

21 January 2018

Meta-analysis: duration of first-line proton-pump inhibitor based triple therapy for Helicobacter pylori eradication

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04902.X

21 January 2018

A randomized comparison of quadruple and triple therapies for Helicobacter pylori eradication: The QUADRATE Study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04902.X

21 January 2018

One-week triple vs. quadruple therapy for Helicobacter pylori infection - a randomized trial.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04902.X

21 January 2018

Systematic review and meta-analysis: levofloxacin-based rescue regimens after Helicobacter pylori treatment failure.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04902.X

21 January 2018

New concepts of resistance in the treatment of Helicobacter pylori infections

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04902.X

21 January 2018

Review article: non-bismuth quadruple (concomitant) therapy for eradication of Helicobater pylori.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04902.X

21 January 2018

A new highly effective short-term therapy schedule for Helicobacter pylori eradication

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04902.X

21 January 2018

High eradication rates of Helicobacter pylori with a new sequential treatment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04902.X

21 January 2018

The sequential therapy regimen for Helicobacter pylori eradication: a pooled-data analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04902.X

21 January 2018

Ten-day sequential therapy of Helicobacter pylori infection in Thailand

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04902.X

21 January 2018

Sequential and concomitant therapy with four drugs is equally effective for eradication of H pylori infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04902.X

21 January 2018

Ten-day sequential therapy as first-line treatment for Helicobacter pylori infection in Korea: a retrospective study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04902.X

21 January 2018

Sequential treatment for Helicobacter pylori does not share the risk factors of triple therapy failure

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04902.X

21 January 2018

Sequential Therapy for Helicobacter Pylori Eradication: The Time is Now!

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04902.X

21 January 2018

Pharmacokinetics and pharmacodynamics of the nitroimidazole antimicrobials

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04902.X

21 January 2018

Understanding and appreciating sequential therapy for Helicobacter pylori eradication

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04902.X

21 January 2018

Therapy for Helicobacter pylori infection can be improved: sequential therapy and beyond

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04902.X

21 January 2018

Identifiers

10.1111/J.1365-2036.2011.04902.X

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22066530%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22066530%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57225807&oldid=2118456240"